Resources with keywords: testing
May 11, 2023, marked the end of the federal COVID-19 public health emergency (PHE) declaration. This doesn’t mean that COVID-19 is over, but the end of the PHE did initiate a cascade of updates to COVID-19 data collection, reporting, and surveillance. Some surveillance metrics will remain the same, but some will change in terms of reporting frequency, data sources, or availability.
Evidence Commons is the first interactive national repository of information on COVID-19 test research.
Self-collection kits and tests are available either by prescription or over the counter in a pharmacy or retail store without a prescription.
The FDA authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening. In addition, 2 serial screening tests were authorized for use in a point-of-care (POC) setting with and without a prescription.
Updated information on available serologic tests. Updated information on relationship between presence of anti-SARS-CoV-2 antibodies and immunity from subsequent infection. Guidance on interpretation of SARS-CoV-2 serologic tests performed on persons previously vaccinated for SARS-CoV-2. Guidance for quarantine of seropositive persons who have had recent exposure to someone with suspected or confirmed COVID-19.
Provides updated guidance for Point-of-Care testing for SARS-CoV-2.
Pray IW, Ford L, Cole D, et al.
